2024 Speakers

Ellen Turner

Ellen Turner

Medical Officer

US Food & Drug Administration (FDA)

Chrysi Sergaki

Microbiome Group Leader

MHRA

Andrew Nealon

Andrew Nealon

Partner

Joyance Partners

Denise Kelly

Investment Advisor

Seventure Partners

Caleb Bell

Venture Partner

Corundum Systems Biology

Silvia Caballero

Program Officer, Microbiome Products

Bill & Melinda Gates Foundation

Koji Yasuda

Principal

Fast Track Initiative Inc

Adam Harvey

Associate Director - Clinical Research, Global Clinical & Translational Sciences

Ferring Pharmaceuticals

Mariia Taguer

Scientist, Microbiology and Bioengineering

Merck & Co

Dylan Lawrence

Research Scientist

Washington University in St. Louis, Pfizer

Ken Blount

Chief Scientific Officer

Rebiotix, A Ferring Company

Adam Wilkinson

Vice President - Pre-Clinical Development

Microbiotica

Amir Zarrinpar

Founder & Chief Medical Officer

Endure Bio

Becca Senter

Vice President, Head of Preclinical R&D

Axial Therapeutics, Inc.

Caitlin Hall

Head of Research

Myota Health

Chris McChalicher

Vice President - CMC Technology Development & Chemical Hygiene Officer

Seres Therapeutics

Colleen Acosta

Chief Executive Officer

Freya Biosciences

Dan Brownell

Head of Research & Development

AOBiome

Daniel van der Lelie

Chief Executive & Scientific Officer

Gusto Global

Elran Haber

CEO

Biomica Ltd.

Evelina Vågesjö

Chief Executive Officer

Ilya Pharm AB

Gary Fanger

Chief Executive Officer

Rise Therapeutics

Greg Medlock

Director - Research

Vedanta Biosciences

Herve Affagard

Founder & Chief Executive Officer

Maat Pharma

Hiroto Tamura

Director of Business Management Division

Metagen Therapeutics

Jun Terauchi

Chief Scientific Officer

Metagen Therapeutics

Kolby Day

Chief Operating Officer

BiomeBank

Marc Tewey

Chief Executive Officer

Exegi Pharmaceuticals

Nikole Kimes

Founder & Chief Executive Officer

Siolta Therapeutics

Olaf Larsen

Senior Manager Science & Management Team & Professor , One Health Innovation, Athena Institute

Yakult Netherlands & Vrije Universiteit Amsterdam

Vanesa Natalin Rocha Martin

Chief Executive Officer

SURI BioTech

Paul Miller

Chief Scientific Officer

Piton Therapeutics

Richard Day

Vice President - Medical Affairs & Clinical Development

ADM

Robert Brucker

Co-founder & Chief Scientific Officer

DermBiont

Robert Mills

Scientific Director

Piton Therapeutics

Sam Possemiers

Chief Executive Officer

MRM Health

Siobhan Cowley

Biological Regulatory Review Specialist

FDA/CBER/OVRR/DBPAP

Andrew Bartko

Executive Director - Center of Microbiome Innovation

UC San Diego

Giulio Maria Pasinetti

The Saunders Family Chair and Professor of Neurology, Psychiatry, Neuroscience, Geriatrics & Adult Development

Icahn School of Medicine at Mount Sinai

Katy Patras

Assistant Professor

Baylor College of Medicine

Nadim Ajami

Executive Director, Scientific Research, Platform for Innovative Microbiome & Translational Research (PRIME-TR)

MD Anderson Cancer Center

James Morton

Consultant

Simons Foundation

Ada Lam

Research Analyst

Beacon Microbiome

Claire Derlot

Chief Business Officer

Biose Industrie

Jason Ryan

Head of Scientific Development & Microbiome

Sacco System Australia

Manoj Dadlani

Manoj Dadlani

President & Chief Commercial Officer

CosmosID

2024 EVENT GUIDE
PRE-CONFERENCE DAY